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ABSTRACT
Bacillus subtilis phage F29 protein p6 is required for
DNA replication and promotes the switch from early to
late transcription. In vivo it binds all along the viral
linear DNA, which suggests a global role as an archi-
tectural protein; in contrast, binding to bacterial DNA
is negligible. This specificity could be due to the p6
binding preference for less negatively supercoiled
DNA,as ispresumably thecase with viral (with respect
to bacterial) DNA. Here we demonstrate that p6 bind-
ing to F29 DNA is greatly increased when negative
supercoiling is decreased by novobiocin; in addition,
gyrase is required for DNA replication. This indicates
that, although non-covalently closed, the viral gen-
ome is topologically constrained in vivo. We also
show that the p6 binding to different F29 DNA regions
is modulated by the structural properties of their
nucleotide sequences. The higher affinity for DNA
ends is possibly related to the presence of sequences
in which their bendability properties favor the forma-
tion of the p6–DNA complex, whereas the lower affi-
nity for the transcription control region is most
probably due to the presence of a rigid intrinsic
DNA curvature.
INTRODUCTION
From higher eukaryotes to bacteria, non-sequence-specific,
DNA binding proteins assume the essential function of packag-
ing and organizing the genome inside the cell. These archi-
tectural proteins, far from merely compacting DNA to fit it into
the cell or nuclear compartment, control DNA structure, topo-
logy and accessibility to proteins to regulate such functions as
replication, transcription, recombination, repair and segrega-
tion. In Eukarya, histones compact and scaffold chromosomes
into a chromatin fiber formed by nucleosomes. The structure
of chromatin can be modulated by covalent modification of
histones, DNA methylation or the interaction with non-histone
proteins such as heterochromatin protein 1 and high mobility
group (HMG) proteins (1,2). The HMG group is a family of
proteins that seems to be involved in the manipulation of
nucleoprotein complexes and in chromatin structure mainte-
nance (3,4). On the other hand, SMC proteins, condensins and
cohesins are ATPases that form complexes with other proteins
to perform an essential role in chromosome condensation,
cohesion, transcriptional control, recombination and repair
(5,6).
In Eubacteria, it has been proposed that a heterogeneous
group of proteins, denominated ‘histone-like’ according to a
functional criterion, is responsible for genome organization
[for reviews see (7,8)]. In Escherichia coli the most abundant
ones are HU, Fis, H-NS, IHF, Dps and StpA (9); they are
mostly non-sequence-specific and it is proposed that they
are distributed along the entire nucleoid (10). E.coli contains
a protein, MukB, with a structure similar to that of SMC (11).
In Bacillus subtilis, ‘histone-like’ proteins such as HBsu (12),
LrpC (13) and L24 (14) have been described. A single SMC
protein is also found in B.subtilis. Both SMC and MukB are
essential for chromosome condensation, supercoiling and cor-
rect partitioning (15). Recently, two highly conserved prokar-
yotic proteins, ScpA and ScpB, have been shown to interact
with SMC, performing similar functions (16,17).
The B.subtilis phageF29-encoded protein p6 is essential for
DNA replication in vivo (18,19), activating in vitro the initia-
tion step (20,21). It is also involved in transcription control,
repressing C2 early promoter at the DNA right end (22–24)
and, together with the viral regulatory protein p4, repressing
early promoters A2b/A2c and activating late promoter A3
(25). In vitro both the stimulation of initiation of DNA repli-
cation and the repression of early promoters require the for-
mation of a protein p6–DNA nucleoprotein complex, in which
the DNA forms a right-handed toroidal superhelix around a
multimeric protein core (26,27). However, in vivo protein p6
binds to most, if not all, of theF29 DNA (28), so its functions in
replication and transcription could be outcomes of a more
global role as a histone-like protein which participates in
organization and compaction of the viral genome. In fact,
its small size and abundance in infected cells [700 000
copies per cell, (29)] are features expected for a protein
with such an architectural role. Like p6, the four major
histone-like proteins of E.coli, HU, IHF, Fis and H-NS are
also involved in transcription control (30,31), particularly H-
NS, which controls the expression of at least 5% of the genes in
the cell (32,33). In addition, the ability to stimulate initiation
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of replication has been described for proteins HU and IHF
(7,34,35).
Protein p6 binding is inversely proportional to the degree of
negative supercoiling of DNA, as shown in vivo and in vitro
(28), in agreement with its in vitro ability to restrain positive
supercoiling [DLk of +0.1 per protein p6 dimer, (27)]. In vivo,
protein p6 binding to all the F29 DNA regions analyzed was
much higher than binding to a negatively supercoiled plasmid
(28), most probably indicating that the F29 genome has a
lower negative superhelicity than the plasmid. In fact, F29
DNA has a terminal protein and therefore is not covalently
closed, but this does not necessarily mean that it is relaxed, as
attachment of the terminal proteins to the membrane could
topologically restrain the genome. Thus, the first question we
address in this paper is whether the F29 genome is topologic-
ally constrained in vivo. If this is so, we could expect improved
p6 binding to DNA after novobiocin treatment; in addition,
DNA replication would be impaired by using the gyrase inhi-
bitors novobiocin and nalidixic acid. The second question was
to find out the reason for the differences in protein p6 binding
to the different F29 DNA regions, namely the enhanced affi-
nity for both DNA ends and the particularly low affinity for the
region comprising the main promoters A2b-A2c-A3 (28). We
considered two main hypotheses: the presence of independent
topological domains, as found in bacterial genomes (36,37),
and preferential binding to certain nucleotide sequences (38).
For this we have studied p6 binding to isolated F29 DNA
regions: in vivo by crosslinking and chromatin immunopreci-
pitation (X-ChIP) and in vitro by fluorescence quenching.
We conclude that F29 DNA is topologically constrained
in vivo, a feature that may be essential for the regulation of p6
functions. In addition, the observed in vivo differences in p6
affinity amongF29 DNA regions seem to depend on structural
features of nucleotide sequences rather than on the existence of
independent topological domains.
MATERIALS AND METHODS
Bacteria, plasmids and phages
B.subtilis 110NA (trpC2, spoOA3, su) (39) containing the
pUB110 derivative pPR55ow6 (40) and E.coli l lysogen
k-12Dtrp (lNcI857DH1) (K-12DH1Dtrp) containing plasmid
pRP8, a pBR322 derivative with the F29 gene 6 under the
control of l thermosensitive promoter PL (20), were used.
Plasmid pACYC184 was obtained from Mobitech. Bacteria
were grown in Luria–Bertani (LB) medium supplemented with
5 mM MgSO4. E.coli harboring pRP8 and pACYC184 plas-
mids was grown in the presence of 100 mg/ml ampicillin and 34
mg/ml chloramphenicol. Phage F29 sus14 (1242), a delayed
lysis mutant (41), was used for the infections.
Enzymes, drugs and reactives
Micrococcal nuclease was from Amersham Pharmacia
Biotech and proteinase K from Boehringer Mannheim. Protein
A-Sepharose CL-4B, lysozyme, RNase A, chloramphenicol,
novobiocin and nalidixic acid were from Sigma. Formalde-
hyde at 37% was purchased from Calbiochem. Restriction
enzymes, Klenow fragment, Vent DNA polymerase,
polynucleotide kinase and T4 ligase were from New England
Biolabs. Alkaline phosphatase was from Promega.
DNAs and oligonucleotides
Proteinase-K-digestedF29 DNA was obtained as described in
(42). DNA fragments for fluorescence analyses were obtained
by PCR in a Light-Cycler apparatus (Roche). A pre-heating
step of 20 min at 95C was performed to activate the poly-
merase, followed by 30 amplification cycles. The PCR con-
ditions and the F29 DNA coordinates of the fragments are
shown in Table 1. The sequences of the primers are available
upon request.
Cloning of F29 DNA fragments in p6-producing
E.coli cells
Recombinant plasmids derived from pACYC184 were con-
structed by inserting into the EcoRV site the DNA fragments
named L, R, C and AO. Blunt-ended F29 terminal fragments
(L, R) were obtained by digestion of plasmids pL259 and
pR259, respectively (43), with DraI and EcoRV. The (24)12
concatemer (C) was obtained from plasmid p(24)12, a pUC19
derivative (27), digested with BamHI and HindIII and filled in
with Klenow fragment to generate blunt ends. The fragment of
E.coli nadB gene for L-aspartate oxidase (AO) was obtained by
PCR, using Vent DNA polymerase. The fragments were then
phosphorylated and purified from agarose gel using the
Quiaquick Gel Extraction Kit (Qiagen). Plasmid
pACYC184 was digested with EcoRV, dephosphorylated,
purified from agarose gel and ligated to each of the four
fragments. E.coli NF1 cells were transformed by electropora-
tion and recombinants analyzed by restriction with BamHI and
HindIII, followed by sequencing of the insert.
Crosslinking, immunoprecipitation and DNA
amplification
X-ChIP was performed essentially as described in (44), with
slight modifications. Bacteria were grown at 30C up to
108 cells/ml. B.subtilis was infected with F29 sus14 (1242)
at a multiplicity of infection of 10. E.coli harboring plasmid
pRP8 was incubated at 37C for 15 min to induce p6 synthesis.
Culture samples, 20 ml each, were treated directly with 1%
formaldehyde, together with 10 mM sodium phosphate,
pH 7.2. After 5 min at room temperature without shaking,
reactions were stopped by addition of 125 mM glycine.
Table 1. DNA fragments used in this work
Fragment F29 DNA PCR conditions
name coordinates Melting Hybridization Elongation
L 1–259 15 s, 95C 5 s, 53C 15 s, 72C
4.9 4752–5087 15 s, 95C 10 s, 48C 60 s, 72C
5.1 4895–5257 15 s, 95C 10 s, 48C 60 s, 72C
5.3 5134–5462 15 s, 95C 10 s, 48C 60 s, 72C
7.4 7255–7528 15 s, 95C 10 s, 51C 30 s, 72C
9.7 9507–9820 15 s, 95C 10 s, 51C 30 s, 72C
11.7 11567–11778 15 s, 95C 5 s, 53C 15 s, 72C
R 18988–19285 15 s, 95C 5 s, 50C 40 s, 72C
C n.a. 15 s, 95C 10 s, 58C 40 s, 72C
PCR amplification conditions and coordinates from F29 DNA left end of the
DNA fragments used for cloning (Figure 3) and/or fluorescence quenching
assays (Figures 4 and 5). n.a.: Not applicable.
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Cells were harvested by centrifugation, washed twice with
PBS buffer, resuspended in 1 ml of buffer A (10 mM
Tris–HCl, pH 8.0, 50 mM NaCl, 10 mM EDTA) with
3 mg/ml lysozyme, incubated for 30 min at 37C and lysed
by addition of 1 ml of 2· IP buffer (100 mM Tris–HCl, pH 7.0,
300 mM NaCl, 2% Triton X-100) with 0.1% SDS. Then, 0.05 U
of micrococcal nuclease, together with 13 mM CaCl2, were
added. After 10 min at 37C, digestion was stopped with
20 mM EDTA, and DNA was sheared to an average size of
750 bp by sonication, eliminating cell debris by centrifugation.
One-twentieth of each sample was kept for total DNA analysis
and the remainder was divided into two equal aliquots to
perform immunoprecipitation overnight at 4C, with 20 ml
of either ap6 polyclonal antibodies or pre-immune serum,
followed by incubation for 2.5 h at 4C with 120 ml of a
25% protein A-Sepharose slurry. Complexes were collected
by centrifugation and washed twice with 1· IP-0.1% SDS
buffer, three times with 1· IP buffer and twice with TE buffer.
The slurry was resuspended in 150 ml of TE buffer containing
1% SDS to disrupt immune complexes. Total DNA samples
(T) were also brought to a total volume of 150 ml TE contain-
ing 1% SDS. All samples were incubated overnight at 65C
with shaking to reverse crosslinks. Slurry was removed by
centrifugation and the supernatant transferred to a fresh tube.
DNA was purified by phenol:chloroform extraction, ethanol-
precipitated and finally resuspended in water.
Analysis of DNA samples was performed by real-time PCR
in a Light-Cycler instrument using a ‘Light Cycler-FastStart
DNA Master SYBR Green I’ hot-start reaction mix (Roche).
The data were interpolated to a standard curve constructed
with known amounts of purified, full-length, F29 or plasmid
DNA. The results were expressed as picograms of F29 or
plasmid DNA per milliliter of culture. Protein p6 binding
was expressed as the immunoprecipitation coefficient (IC);
IC = [(ap6pi)/T] · 106, where T is total DNA, ap6 the
DNA immunoprecipitated with serum against p6 and pi the
DNA immunoprecipitated with pre-immune serum.
In the case of infected B.subtilis the amplification conditions
for F29 DNA were those described for obtaining DNA frag-
ments for fluorescence assays (see above). Fragment L corres-
ponds to region F1, 5.1 to region F2, 7.4 to region F3, 9.7 to
region F4, 11.7 to region F5 and R to region F6. For E.coli
cells containing pACYC184 derivatives, regions P1 (positions
1612–1711, without considering the length of the insert) and
P2 (3607–3979) were amplified. The PCR was performed as
for F29 DNA, with a hybridization step of 10 s at 58C for P1
and 52C for P2, and an elongation of 40 s at 72C for both. In
all cases, a melting analysis was performed by continuous
fluorescence measurement from 65 to 95C, to ensure the
presence of a single specific amplification product.
Fluorescence measurements
Fluorescence measurements were performed in a Varian Cary
Eclipse spectrofluorometer and monitored in a 2 mm path
length cell, at a temperature of 15C. The tryptophan residue
of protein p6 was excited at a wavelength of 290 nm and
fluorescence measured at 350 nm.
To determine the effective binding constant (Keff = Kw) of
protein p6 to the different DNA fragments, direct titration
experiments were performed (45,46). Protein p6 was added
to DNA (20 mM) in a buffer of 50 mM Tris–HCl, pH 7.5,
10 mM MgCl2, measuring fluorescence after mixing the sample
by gentle shaking and incubating for 15–45 s. To calculate
the Keff, we carried out a fitting procedure based on pre-
viously published expressions (45) and on the theory of
McGhee and von Hippel (47), for the binding of proteins
to polynucleotides. The fitting procedure was started by fix-
ing the values of Qmax, fA and the binding site size (n) and
setting K and w as the fitting parameters, and continued by an
iteration algorithm designed in our laboratory (48). We also
performed a graphical approximation to Keff as described in
(46). In a plot of the saturation fraction against [p6]free,
assuming that w  n, the value of [p6]free corresponding
to half saturation yields 1/Kw (47,49).
RESULTS
The F29 genome is topologically constrained in vivo
PhageF29 protein p6 binds all along F29 DNA in vivo with a
much higher affinity than for plasmid DNA. This could be due
to a lower negative superhelicity of F29 DNA, as negative
supercoiling impairs p6 binding to DNA (28). Although phage
F29 DNA has a terminal protein, and therefore is not
covalently closed, it could be topologically constrained, as
described for bacteriophage T4 (37). To study this possibility,
we used X-ChIP (50) and real-time PCR to measure p6 binding
in vivo to six regions scattered throughout the F29 genome
(F1 to F6, see Figure 1A) in the absence or presence of
novobiocin. Novobiocin produces a loss of negative super-
coiling (51), so if F29 DNA were topologically constrained,
we would expect an increase of p6 binding. As a control, we
used nalidixic acid, which also inhibits gyrase but has no
topological effects. It is important to note that the analyzed
regions include a much wider region (1.2 kb, in gray) than
the PCR-amplified sequences (300 bp, in black), as the aver-
age size of the DNA fragments after sonication is 750 bp.
Figure 1B shows that protein p6 binding, expressed as the
immunoprecipitation coefficient (IC, see Materials and Meth-
ods), increases 23- to -35-fold with respect to the control upon
addition of novobiocin, except in the case of regionF2, where
the increase is about 8-fold. Although binding to allF29 DNA
regions is dramatically increased by novobiocin, the differ-
ences observed among them in the absence of inhibitors are
qualitatively conserved. Nalidixic acid produced essentially
no change in the IC values. These results suggest that F29
DNA, although not covalently closed, is topologically con-
strained in vivo.
To further investigate this issue we studied the effect of
gyrase inhibitors in F29 DNA replication. The origins of
replication of F29 DNA are located at the ends of the linear
genome. Progression of the two replication forks would gen-
erate positive supercoiling ahead due to DNA unwinding that
would greatly impair replication if DNA were not allowed to
rotate freely. Thus, in a topologically restricted DNA, gyrase
would be required for efficient replication. Therefore, we
added novobiocin or nalidixic acid 30 min post-infection,
once phage DNA replication had started, and measured
DNA synthesis. Samples were taken 40 and 80 min post-
infection and DNA extracted and analyzed by agarose gel
electrophoresis (Figure 2A). Using real-time PCR we also
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quantified accurately the amount of DNA from the left F29
DNA terminus (Figure 2B), shown in black in Figure 1A. Both
stained gels and PCR analysis clearly indicate that the two
inhibitors, especially novobiocin, already produce a significant
impairment in DNA replication 10 min after their addition.
Altogether these results indicate that the F29 genome is topo-
logically constrained in vivo and, on the other hand, that gyrase
is the first host protein shown to participate in F29 DNA
replication.
Protein p6 binding to F29 DNA ends cloned in E.coli
The enhanced binding of p6 to regions F1 and F6, which
contain the F29 DNA ends, could be due to the presence of
independent topological domains in F29 DNA and/or to the
presence of preferential binding sequences. To discriminate
between these two possibilities we analyzed p6 binding in vivo
to different F29 DNA regions in the same topological envir-
onment. For this, we cloned the left (L) or right (R) F29 DNA
ends in plasmid pACYC184 at the region denominated P1 (see
Figure 3A), and transformed a p6-producing E.coli strain.
These inserts basically correspond to the amplified sequences
of region F1 (L) and F6 (R). We also measured p6 binding to
a concatemeric sequence (C) for which footprinting assays
showed a preferential p6 binding in vitro (27). This concate-
mer contains 12 repetitions of a 24 bp sequence that would
theoretically favor the formation of the p6-DNA complex (38),
according to its predicted anisotropic bendability based on the
algorithm developed by Travers and coworkers (52). As con-
trol, we used the pACYC184 plasmid with an insert of similar
size of a non-related DNA sequence, a fragment of E.coli
aspartate oxidase gene (AO). As internal control in every
construction we measured p6 binding to a region, P2, of simi-
lar size located at the opposite site (see Figure 3A).
As Figure 3B shows, p6 binding for the concatemeric region
(C) is 1.5- and 1.8-fold higher than for the left (L) and right (R)
F29 DNA ends, respectively, and over 5-fold higher than for a
non-F29 DNA sequence (AO). Binding to region P2 was
similar in all cases, being slightly lower when binding to
the corresponding region P1 was higher; as p6 restrains
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Figure 1. Effect of novobiocin and nalidixic acid in protein p6 binding toF29 DNA. (A) Genomic location of theF29 DNA regions analyzed for protein p6 binding.
The positions of the genes, numbered 1 to 17, are indicated, .5 to .9 stands for genes 16.5 to 16.9. The 50-bound terminal protein is depicted as a black circle. The arrows
point the direction of transcription: early promoters C2, A2b and A2c transcribe leftwards and late promoter A3 rightwards. SixF29 DNA regions, namedF1 toF6,
were analyzed. Regions F1 and F6 correspond to the left and right F29 DNA ends, respectively; F6 also comprises early promoter C2. F2 includes the central
transcriptional control region, with promoters A2b, A2c and A3. The analyzed regions include the PCR-amplified sequences,300 bp long (black rectangles), and
the flanking 450 bp (gray), as the average size of DNA after sonication is 750 bp. The amplified sequences were purified and used for fluorescence quenching
assays (Figures 4 and 5). These DNA fragments were named L (left DNA end, comprised in regionF1), 5.1 (comprised inF2), 7.4 (comprised inF3), 9.7 (comprised
inF4), 11.7 (comprised inF5) and R (right DNA end, comprised inF6). (B) Protein p6 binding toF29 DNA regions. B.subtilis cells were grown, infected withF29
sus14 (1242) and, after 20 min, the untreated aliquot () was crosslinked and processed as described in Materials and Methods; other two aliquots were treated with
34 mg/ml chloramphenicol together with 500 mg/ml novobiocin (Nov) or nalidixic acid (NA), and crosslinked 10 min later. Protein p6 binding is expressed as
immunoprecipitation coefficient (IC, see Materials and Methods). IC values for each region are the following (, Nov, NA).F1: 1935, 67448, 2320;F2: 230, 1760,
105; F3: 344, 9753, 151; F4: 458, 16059, 254; F5: 392, 9063, 238; F6: 1369, 46812, 915.
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positive supercoiling, binding to high affinity sequences could
originate compensatory negative supercoils along the free
DNA, impairing further p6 binding (28). In conclusion, the
higher affinity of p6 for regions F1 and F6 in F29-infected
cells could be explained by the existence of nucleotide seq-
uences that favor the formation of the nucleoprotein complex.
Protein p6 binding in vitro to F29 DNA sequences
To further investigate the role of the nucleotide sequence in
protein p6 binding, we performed in vitro p6 binding assays
using tryptophan fluorescence quenching, which allows cal-
culation of the binding constant for a given DNA. We assayed
all the amplified sequences (fragments ranging from 212 to
366 bp in length) from the six F29 DNA regions, F1 to F6,
analyzed in vivo (see Figure 1A). It is very important to note
that the p6 binding data in vivo (Figure 1B) correspond not
only to the amplified sequence (in black in Figure 1A), but to
the whole immunoprecipitated region (in gray in Figure 1A).
Therefore, although correlated, the in vivo and in vitro data are
not directly comparable. Thus, to avoid any confusion, we
named theF29 DNA fragments according to their coordinates
(in kb): 5.1 from region F2, 7.4 from region F3, 9.7 from
region F4 and 11.7 from region F5. L and R stand for the left
and right DNA termini, from regionsF1 andF6, respectively.
To determine the effective binding constant (Keff) values for
the different DNA fragments we performed direct titration
experiments (45,46) in which increasing amounts of p6
were added to 10 mM (bp) of the six fragments, L, 5.1, 7.4,
9.7, 11.7 or R (Figure 4A). At low protein concentration fluor-
escence values follow a straight line whose slope corresponds
to the free protein. At a given concentration p6 begins to bind
DNA, fluorescence is quenched and therefore the slope
decreases. The inset of Figure 4A shows, enlarged, the p6
binding in the range 0.7–1.7 mM. Finally, when the protein
saturates DNA, the initial slope is recovered, as the
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Figure 2. Effect of novobiocin and nalidixic acid on F29 DNA replication.
B.subtilis cells were infected withF29 sus14 (1242) and 30 min later the culture
was divided into three aliquots and further grown in the presence of novobiocin
(Nov), nalidixic acid (NA) (500 mg/ml each) or none (). Aliquots were taken at
the indicated times after infection, and the DNA was purified by phenol
extraction and ethanol precipitation. (A) Agarose gel electrophoresis
showing viral (lower band) and chromosomal DNA (upper band). (B)
Amount of F29 DNA calculated by real time PCR of the left terminal
sequence (259 bp). The data are expressed as nanograms of full-length F29
DNA per milliliter of culture.
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Figure 3. Protein p6 binding to DNA regions cloned in plasmid pACYC184.
(A) Genetic map of plasmid pACYC184, indicating the EcoRV restriction site
in region P1 (100 bp) in which the following sequences were inserted: F29
DNA left (L) and right (R) termini, a concatemer formed by 12 tandem repeats
of a 24 bp p6 preferential binding sequence (C, see text for details) and an E.coli
aspartate oxidase gene fragment (AO). The amplified sequences, P1 and P2, are
depicted in black, and the DNA regions analyzed for p6 binding are shown in
gray. Plasmid origin of replication and chloramphenicol and tetracycline
resistance genes are also shown. (B) Protein p6 binding to DNA regions.
Protein p6-producing E.coli cells were transformed with each of the four
recombinant plasmids described in (A). The four strains were grown to
108 cells/ml, 500 mg/ml novobiocin was added to increase p6 binding
sensitivity, and after 10 min, cells were crosslinked and processed as
described in Materials and Methods. Protein p6 binding is expressed as
immunoprecipitation coefficient (IC, see Materials and Methods). IC values
of regions P1 and P2 for the following inserts were, respectively, L, 9530 and
1289; R, 7890 and 1139; C, 13978 and 345; and AO, 2724 and 1103.
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fluorescence values correspond again to the free protein.
Therefore, the affinity of p6 for the DNA fragments can be
easily compared from these graphs. Figure 4A shows that
fragments R and, particularly, L have the highest affinity:
p6 starts to bind at a lower concentration, the slope of the
binding phase is the lowest and saturation is rapidly reached.
Next follow the affinities for 9.7 and 7.4 and then 11.4, which
only approaches saturation at high p6 concentrations. Finally,
p6 binds with the lowest affinity to 5.1 and does not reach
saturation at the highest protein concentration tested.
We computer-fitted the values of the titrations to Keff values
(see Materials and Methods) for each DNA in terms of
the previously calculated value of maximal quenching
[Qmax = 0.84, (28)], the molar fluorescence of the free protein
(fA = 231 mM1) and the binding site size of a protein p6
monomer [n = 12, (26)]. The values of the Keff (in M1)
are as follows. L: 13.6 · 105; 5.1: 4.0 · 105; 7.4: 8.0 · 105;
9.7: 10.0 · 105; 11.7: 6.0 · 105 and R: 12.4 · 105. We have also
performed a graphical approximation to the Keff values
(Figure 4B). In a plot of the saturation fraction (q) against
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Figure 4. Protein p6 binding toF29 DNA sequences measured by fluorescence quenching. (A) Direct titration of p6 binding to the followingF29 DNA fragments: L
(259 bp), 5.1 (363 bp), 7.4 (237 bp), 9.7 (313 bp), 11.7 (212 bp) and R (298 bp). L and R stand for left and rightF29 DNA ends, respectively, 5.1 to 11.7 correspond to
the genome coordinates of the center of the fragments, and they are shown in black in Figure 1A. Therefore, L, 5.1, 7.4, 9.7, 11.7 and R are comprised in regionsF1 to
F6, respectively. Protein p6 was added to 10 mM DNA (in bp), and fluorescence measured continuously. The inset shows, enlarged, the plot in the 0.7–1.7 mM p6
range. (B) Graphical estimation of the Keff of p6 for each fragment, in a plot of the saturation fraction (q) versus concentration of free p6. These values are for a single
representative experiment.
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the free protein, which is derived from the direct titration data,
the inverse of [p6]free when 50% of the DNA is bound to
protein is approximately the value of Keff. The values obtained
(L: 13.5 · 105; 5.1: 4.0 · 105; 7.4: 8.9 · 105; 9.7: 10.4 · 105;
11.7: 6.7 · 105 and R: 12.5 · 105) are close to those calculated
directly from Figure 4A.
As stated previously, p6 preferential binding to F29 DNA
terminal regions could be due to the presence of sequences
with anisotropic bendability that favors the formation of the
nucleoprotein complex. We have just shown that p6 binding
in vivo to a concatemer of 12 repetitions of such a sequence,
named fragment C, is higher than that to F29 DNA ends
(Figure 3). In addition, p6 binding in vitro to fragment C
was measured by fluorescence quenching and directly com-
pared with binding to L, the F29 fragment with highest affi-
nity. The lowest binding affinity corresponded to fragment 5.1,
which contains an intrinsic DNA curvature (53,54), whose
rigid structure could impair p6 binding. To test this hypothesis,
we measured p6 affinity for two overlapping fragments in
which the 50 bp curved tract was excluded (Figure 5A).
These fragments, named 4.9 and 5.3 after their genome
coordinates, are similar in size to fragment 5.1. Figure 5B
shows a direct titration of p6 by fragments C, 4.9 and 5.3,
along with fragments L and 5.1 for comparison. It is clear that
p6 affinity for fragment C is higher than for any other frag-
ment. The calculated Keff value is 26.2 · 105, nearly twice that
for L (13.5 · 105). As for fragments 4.9 and 5.3, their Keff
values are 9.4 · 105 and 8.8 · 105, respectively, more than
twice that of fragment 5.1 (4.0 · 105). Figure 5C shows a
graphical approximation to the constants, as in Figure 4B.
Again, the Keff values are very similar, 25.0 · 105 for fragment
C, 9.8 · 105 for 4.9, and 8.8 · 105 for 5.3. These results
strongly suggest that the structural properties of a given
DNA sequence may determine the p6 binding affinity.
DISCUSSION
In addition to its well characterized function in DNA replica-
tion and transcriptional control (55), protein p6 binds in vivo to
most, if not all, of theF29 DNA (28), which strongly suggests
a role in the global organization and compaction of the viral
genome. Its small size and abundance in infected cells
[700 000 copies per cell, (29)] are features expected for a
protein with an architectural role. Protein p6 does not recog-
nize a specific DNA sequence; however, in infected cells it
can discriminate viral from bacterial DNA, as binding to
plasmid DNA is negligible (28). Binding to plasmid DNA
in vivo increases dramatically upon addition of novobiocin,
which inhibits gyrase, producing a decrease in negative super-
coiling. The p6 supercoiling-dependent binding was confirmed
and quantified by in vitro studies (28) and it is consistent with
the ability of p6 to restrain positive supercoiling (27,56).
Therefore, the specificity of p6 forF29 DNA is most probably
based on its preferential binding to DNAs with lower negative
superhelicity, as is presumably the case of the non-covalently
closedF29 genome with respect to host DNA. In this work, we
demonstrate that F29 DNA, although it has a terminal protein
covalently linked to the ends, and therefore is not covalently
closed, is topologically constrained. Evidence supporting F29
DNA topological restriction is 2-fold. First there is the nearly
30-fold increase of p6 binding upon novobiocin treatment, as
was described for plasmid DNA (28). Novobiocin inhibits
gyrase, producing a loss of negative supercoiling; if F29
DNA were unconstrained, novobiocin should have no effect.
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Figure 5. Protein p6 binding to DNA fragments measured by fluorescence
quenching. (A) Diagram of F29 DNA fragments 4.9, 5.1 and 5.3, showing
the position of the curved region of fragment 5.1. Fragments 4.9 and 5.3 overlap
fragment 5.1 but lack the intrinsic curvature; 4.9 and 5.3 stand for theF29 DNA
coordinates of the center of the fragment. (B) Direct titration of p6 binding to the
following DNA fragments: L (259 bp) and 5.1 (363 bp) are the F29 DNA
fragments described in Figure 4A; 4.9 (335 bp) and 5.3 (328 bp) are the
fragments shown in (A), and C (350 bp) is a 12 tandem repeats concatemer
of a 24 bp sequence of p6 preferential binding. (C) Graphical estimation of the
Keff values of p6 for each fragment, in a plot of the saturation fraction (q) versus
concentration of free p6.
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In contrast, nalidixic acid, which also inhibits gyrase but pro-
duces no topological change (51) did not increase p6 binding.
The second piece of evidence for topological restriction is the
inhibition of F29 DNA replication by the gyrase inhibitors,
novobiocin and nalidixic acid. The higher inhibition by novo-
biocin could be due to the increase of p6 binding: an excess of
positive supercoiling would further hinder strand separation
during replication. Therefore, gyrase is required forF29 DNA
replication, being the first host protein shown to be involved in
this process.
This topological constraint is most probably due to mem-
brane attachment (57), presumably through the terminal pro-
teins, which has been shown to have intrinsic affinity for the
membrane (58). In addition, two membrane-associated viral
proteins involved in F29 DNA replication are probably
implicated in this attachment, p16.7 (59) and p1, the latter
proposed to be a component of a scaffold for the assembly
of the viral DNA replication machinery (60).
The topological constraint of F29 DNA may be essential to
understanding the functions of protein p6, namely DNA repli-
cation and the switch from early to late transcription. More
interestingly, other functions for p6 could be envisaged: for
example, it could play a role in segregation of the viral DNA
progeny. It has been shown that throughout the infective cycle
F29 DNA undergoes a dynamic relocalization, spreading into
multiple replication foci (61). The protein p6-induced positive
supercoiling, leading to DNA compaction, may be essential
for this process in a way similar to that proposed for bacterial
chromosome partitioning (62). In E.coli this partitioning
requires MukB protein, which is known to be involved, like
protein p6, in DNA condensation and supercoiling (63). In
B.subtilis, MukB equivalent Smc protein is also involved in
chromosome condensation and partitioning through supercoil-
ing (64); a eukaryotic SMC, condensin 13S, restrains toroidal
positive supercoiling in vitro (65), just as protein p6 does.
Thus, protein p6 could be functionally equivalent to Smc
proteins for the viral DNA segregation process.
Once it has been determined that the F29 genome is con-
strained, the simplest model would assume a single topological
domain in F29 DNA. However, the fact that p6 binds to DNA
regions with different affinities could be explained by the
existence of independent topological domains. The evidence
shown in this paper argues against this hypothesis. The p6
binding preferences for different regions remained unchanged
after novobiocin addition (Figure 1B), and are also maintained
in vitro (Figure 4A and B). In Figure 6 we show the data for p6
binding to F29 DNA in vivo and in vitro normalized to those
of region F1 or fragment L, respectively. Although the differ-
ences of p6 binding in vitro among the regions are less pro-
nounced, specifically in terms of terminal versus central
regions, they are qualitatively analogous to the corresponding
F29 DNA regions in vivo.
The preferential binding to the DNA ends is probably due to
the presence of sequences with bendability properties that
favor the formation of the p6–DNA complex, in accordance
with previously published predictions (38). In fact, the 24 bp
sequence of the concatemer used in our studies is highly flex-
ible and is kinked about 90 (66). This preferential binding is
probably related to the p6 activation of replication origins at
both DNA ends (20,21). Another important role of p6 at the
right DNA end is switching off the very early promoter C2,
which controls the expression of proteins involved in phage
DNA injection (67). A high p6 affinity for this region is neces-
sary to ensure a rapid repression of the promoter at the
beginning of the infective cycle, when the p6 concentration
is still low.
The particularly low p6 affinity for the transcription control
region, comprised in fragment 5.1 in vitro and region F2
in vivo, seems to be due to the presence of an intrinsic cur-
vature, located at the protein p4 binding site at promoter A2b
(53,54). The rigidity of this sequence could impair the forma-
tion of the nucleoprotein complex, which, as stated above,
requires bendable sequences. In fact, we show that protein
p6 binding to partially overlapping DNA fragments that
lack the intrinsic curvature is much higher, with affinity values
similar to those of the other internalF29 DNA fragments. The
low p6 binding to region F2 in vivo may be essential for the
correct timing of the transcription program of the phage. Protein
p6 increases binding of p4 to its cognate site at promoter A2b
(25), which induces its repression and the activation of late
promoter A3 (68,69). Given the high synthesis rate of protein
p6, its affinity for this region must be kept low to prevent a
premature switching from early to late transcription, which
would give rise to a shorter infective cycle and a low phage
production.
In conclusion, we show that protein p6 binding toF29 DNA
in vivo is enhanced when cells are treated with novobiocin,
which decreases negative supercoiling, but not when treated
with nalidixic acid, which does not change topology. How-
ever, both novobiocin and nalidixic acid impair viral DNA
replication, indicating the involvement of gyrase in this pro-
cess. Both results lead to the conclusion that the F29 genome
is topologically constrained in vivo. We also show that protein
p6 binding is favored by nucleotide sequences with precise
bendability properties, and impaired by rigid DNA tracts.
The local variations of p6 affinity may be very important
for processes such as DNA replication and regulation of
transcription.
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Figure 6. Comparison of p6 binding toF29 DNA regions in vivo and in vitro. IC
values for in vivo p6 binding to regions F1 to F6, with or without novobiocin
(Nov), are from Figure 1B, and were normalized to those of region F1. Keff
values for in vitro p6 binding to fragments L to R are from Figure 4A, and were
normalized to that of fragment L. The relative binding values were plotted
versus their position in F29 DNA.
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